Perspective Therapeutics Inc (AMEX: CATX) kicked off on Tuesday, up 11.46% from the previous trading day, before settling in for the closing price of $1.92. Over the past 52 weeks, CATX has traded in a range of $1.60-$19.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 1.39% over the last five years. While this was happening, its average annual earnings per share was recorded -2.78%. With a float of $53.81 million, this company’s outstanding shares have now reached $70.67 million.
The firm has a total of 140 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Perspective Therapeutics Inc (CATX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 27.34%, while institutional ownership is 68.21%. The most recent insider transaction that took place on Mar 28 ’25, was worth 49,384. In this transaction Chief Executive Officer of this company bought 22,026 shares at a rate of $2.24, taking the stock ownership to the 59,383 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 4,650 for $2.21, making the entire transaction worth $10,288. This insider now owns 4,650 shares in total.
Perspective Therapeutics Inc (CATX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.72% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Take a look at Perspective Therapeutics Inc’s (CATX) current performance indicators. Last quarter, stock had a quick ratio of 12.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 109.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.21, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.44 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Analysing the last 5-days average volume posted by the [Perspective Therapeutics Inc, CATX], we can find that recorded value of 0.65 million was lower than the volume posted last year of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 75.86%. Additionally, its Average True Range was 0.21.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 17.76%, which indicates a significant decrease from 98.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 103.01% in the past 14 days, which was higher than the 83.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4300, while its 200-day Moving Average is $7.7500. Now, the first resistance to watch is $2.2200. This is followed by the second major resistance level at $2.2900. The third major resistance level sits at $2.4400. If the price goes on to break the first support level at $2.0000, it is likely to go to the next support level at $1.8500. Now, if the price goes above the second support level, the third support stands at $1.7800.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
The company with the Market Capitalisation of 158.47 million has total of 74,051K Shares Outstanding. Its annual sales at the moment are 1,450 K in contrast with the sum of -79,280 K annual income. Company’s last quarter sales were recorded 230 K and last quarter income was -40,170 K.
